AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

The long-duration soft-tissue repair ultrasound device provides healthcare professionals with another proven method of accelerating and enhancing healing.

THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) COVID-19 SCREENING THROUGH ARTIFICIAL INTELLIGENCE / MACHINE LEARNING TECHNOLOGY IS THE NEWEST MEMBER OF BARDA'S DIVISION OF RESEARCH, INNOVATION, AND VENTURES (DRIVe) MEDICAL COUNTERMEASURES PORTFOLIO

SportGait's BKG Gait technology out-predicts leading gait and balance assessments by orders of magnitude.

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.

Born in Venezuela, developmental and molecular biologist Alejandro Sánchez Alvarado receives the $100,000 prize for his contributions to the field of regeneration.

PureWay Compliance, Inc. provides safe sharps (needles, syringes, etc.) disposal to patients that self inject at home and do not wish to discard their needles in the trash. With increasing awareness of the hazards of dirty needles, patients are looking for safe and eco-friendly options to safely dispose of sharps at home. PureWay since 2013 has provided over 300,000 patients with sharps disposal by mail systems through strategic agreements with pharmaceutical manufacturers, non-profits like SafeNeedleDisposal and through stewardship programs.

A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for immunology discovery.

1nHealth presented 941 total patients with opportunities to join relevant online communities with The Mighty

BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics

Effective for Lowering Blood Sugar Plus Appeal of 1x-Month Injection and Potential Slimming

Hashtag Added to Ozempic Medication for TikTok Viewers Pushing Ongoing Shortage

The device's ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.

•• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone
•• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle
•• Amber plans to initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in Q1 2023 ••

The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).

Gb Sciences' innovative approach harnesses the power of plant-based treatments as simplified mixtures that target dangerous hyperinflammatory responses to viral infections.

Two-day virtual training session will give participants the skills to identify and address ethical challenges

The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.

Expert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness.

Company offers the fastest and only multi-touch sensing bionic hand on the market.

Naples, Florida-based complementary and alternative medicine center helps patient restore mobility, confidence and return to daily living.

As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.

At the Annual Summit, Dr. Andrea Small-Howard is presenting a Keynote Address that includes data from case studies demonstrating the utility of Gb Sciences' proprietary PhAROS drug discovery platform.

eSource is the agile response to promote continuity of clinical trials even in uncertain times.